TiGenix (Spain)

TiGenix (Spain)

TiGenix is a European cell therapy company with a proprietary validated allogeneic expanded adipose-derived stem cell platform technology for the treatment of autoimmune and inflammatory diseases, and a commercialized product. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for TiGenix (Spain), Spain, covering academic research published from 2000 to 2025. Read More.


Open Access Percentage

68%


Total
Publications

1.9K


Total Open
Publications

1.3K


Total
Citations

60K


Open Access
Percentage

68%


Total
Publications

1.9K


Total Open
Publications

1.3K


Total
Citations

60K

Wikipedia

Website

download

Breakdown

30% 29% 8% 33%

Publisher Open

30%

Both

29%

Other Platform Open

8%

Closed

33%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

020406080100120140160180200Total Publications
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Open

Closed

Publisher Open

31%OA Journal

OA Journal 31%

347

Hybrid 30%

327

No Guarantees 39%

433

Other Platform Open

Institution 66%

459

Domain 37%

254

Other Internet 20%

138

Preprint 5%

38

Public 3%

22

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
260
doaj.org OAI-PMH Repository
Institution
189
LA Referencia
Institution
93
Unknown Repository
Other Internet
85
DOI
Other Internet
59
aecid.es OAI-PMH Repository
Institution
38
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
33
Royal Netherlands Academy of Arts and Sciences
Institution
26
Hospitais da Universidade de Coimbra
Institution
24
University of Groningen
Institution
15
1 / 19

Data updated 12 August 2026

Share

Share

Share